Respiratory Disorders Flashcards
Client with pneumonia
Infectious:
- Bacteria, viruses, fungi, protozoa, other microbes
Noninfectious:
- Aspiration of gastric contents, inhalation of toxic or irritating gases
Community- acquired:
- Streptococcus pneumoniae most common
Nosocomial (hospital acquired):
- Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginaosa, E. Coli
Opportunistic:
- Pneumocystitis carinii in immunocompromised persons
Collaborative Care:
Prevention if key component, especially with vulnerable populations
Immunization
Pneumococcal vaccine: antigens from 23 types of pneumococcus, imparts life-long immunity
Influenza vaccine: recommended for high-risk populations
Medications
Antibiotics: initially according to gram stain, pattern of lung involvement, then according to C&S results
Bronchodilators: improve ventilation, reduce hypoxia
Sympathomimetics: albuterol, metaproterenol
Methylxanthines: theophylline, aminophylline
Expectorants: Acetylcysteine (Mucomyst) as inhalation; guaifenesin
Respiratory Treatments
Incentive spirometry, suctioning
Oxygen: according to clients needs: range form cannula to intubation and mechanical ventilation
Chest Physiotherapy
Percussion: rhythmic clapping on chest wall to reduce lung consolidation, prevent atelectasis
Vibration: application of pressure with repeated tensing of hand over involved areas to facilitate movement of secretions into larger airways
Postural Drainage: positioning client to facilitate drainage of secretions from lung segment
Complementary Therapies
Herbs: echinacea, goldenseal, ma huang
Nursing Care/ Health Promotion
Vaccinations against pneumonia Preventive measures in high risk groups - Increase mobility - Good hydration, nutrition - Prompt detection and prompt treatment of pneumonia
Nursing Diagnoses
Ineffective airway clearance
Ineffective breathing pattern
Activity intolerance
Home Care
Usually treated in community unless respiratory status compromised
Preventive measures
Recognition of manifestations
Supportive care to maintain clients health
Completion of any antibiotic therapy
Continue with medical appointments for follow-up
TB: Collaborative Care
Significant public health threat with development of drug-resistance strains; focus includes:
- Early detection
- Accurate diagnosis
- Effective disease treatment
- Prevention of spread of TB
Non-compliance with prescribed treatment is a major problem
TB: Treatment
Treatment usually lasts for many months and sometimes years
Successful treatment of TB:
- Depends on the compliance of the patient
- The failure of the patient to take the medications as prescribed is the most important cause of failure to cure TB
- Health department can demand direct monitoring of patient compliance with therapy
TB: Medications
Isoniazid (INH) antibiotic to prevent TB form becoming active
Rifampin (RMP) used for active TB
Pyrazinamide (PZA) used for active TB
Ethambutol (EMB) used for active TB
TB: Medications Prevention and Treatment
Prophylactic treatment to prevent active TB
- Clients with positive TB skin test
- Close contact of persons with positive sputum
6-12 months of Isoniazid orally (300 mg)
Bacilli Calmette -Guerin (BCG) vaccine given to infants
Toronto researchers (October 2013) developed a booster that will reactivate immunity (still in trials)
TB: Treatment
Treatment for active disease uses 2 or more medications to prevent TB organism from mutating into drug-resistant forms
- Initial regimen is 2 months daily treatment with INH, Rifampin, Pyrazinamide, Ethambutol to kill any resistant strains
- 4 more months (or depending on compliance) of two meds depending on C&S
May use Streptomycin if compliance is an issue as it is an injection
TB
Baseline testing prior to antituberculosis drug therapy
- Liver function tests before Isoniazid (INH)
- Vision examination before ethambutol
- Audiometric testing before streptomycin therapy
TB
Twice weekly therapy administered under direct supervision of public health personnel if non compliant
Effectiveness of therapy assessed by repeat sputum specimens and chest x-rays
TB
With adherence to treatment
- negative sputum specimens within 3 months; relapse rate with current treatment is